Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients. (RALDAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01258374
Recruitment Status : Completed
First Posted : December 13, 2010
Last Update Posted : September 2, 2015
Information provided by (Responsible Party):
Josep Mallolas Masferrer, Hospital Clinic of Barcelona